Investigation announced for Investors in shares of Repare Therapeutics Inc. (NASDAQ: RPTX) over possible Breaches of Fiduciary Duties

An investigation was announced over potential breaches of fiduciary duties by certain directors at Repare Therapeutics Inc.

Investors who purchased shares of Repare Therapeutics Inc. (NASDAQ: RPTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Repare Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.

Montreal, Canada based Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States.

On or around June 18, 2020, Repare Therapeutics Inc. conducted its initial public offering ("IPO"), issuing 11 million shares of common stock priced at $20.00 per share.

On February 3, 2023, Morgan Stanley analyst Jeffrey Hung downgraded Repare Therapeutics Inc. to Equal Weight from Overweight. Hung cited concerns over an upcoming Phase 1 readout for the Company's PKMYT1 inhibitor RP-6306, noting that "PKMYT1 is a novel target" and opining that initial Phase 1 data for RP-6306 will focus on Pharmacokinetics, Pharmacodynamics, and proving target inhibition.

Shares of Repare Therapeutics Inc. (NASDAQ: RPTX) declined to as low as $8.53 per share on April 11, 2023.

Those who purchased shares of Repare Therapeutics Inc. (NASDAQ: RPTX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.